{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:07:16Z","timestamp":1776056836210,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T00:00:00Z","timestamp":1360800000000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2013]]},"DOI":"10.6061\/clinics\/2013(01)rc02","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T13:31:58Z","timestamp":1359466318000},"page":"123-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds"],"prefix":"10.1016","volume":"68","author":[{"given":"Mirella Hansen","family":"de Almeida","sequence":"first","affiliation":[]},{"given":"Joana Rodrigues","family":"Dantas","sequence":"additional","affiliation":[]},{"given":"Bianca","family":"Barone","sequence":"additional","affiliation":[]},{"given":"Fabiano Marcel","family":"Serfaty","sequence":"additional","affiliation":[]},{"given":"Rosane","family":"Kupfer","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Albernaz","sequence":"additional","affiliation":[]},{"given":"Maria Rocio","family":"Bencke","sequence":"additional","affiliation":[]},{"given":"Lenita","family":"Zajdenverg","sequence":"additional","affiliation":[]},{"given":"Melanie","family":"Rodacki","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Eg\u00eddio Paulo","family":"de Oliveira","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"9277","key":"10.6061\/clinics\/2013(01)RC02_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(01)05415-0","article-title":"Type 1 Diabetes: new perspectives on disease pathogenesis and treatment","volume":"358","author":"Atkinson","year":"2001","journal-title":"Lancet"},{"issue":"9513","key":"10.6061\/clinics\/2013(01)RC02_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0140-6736(06)68341-4","article-title":"Type 1 Diabetes","volume":"367","author":"Daneman","year":"2006","journal-title":"Lancet"},{"issue":"5","key":"10.6061\/clinics\/2013(01)RC02_bib3","first-page":"96","article-title":"Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse","volume":"48","author":"Screenan","year":"1999","journal-title":"Diabetes"},{"issue":"5","key":"10.6061\/clinics\/2013(01)RC02_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/diacare.23.5.701","article-title":"The function of pancreatic islets isolated from type 1 diabetic patient","volume":"23","author":"Marchetti","year":"2000","journal-title":"Diabetes Care"},{"issue":"2","key":"10.6061\/clinics\/2013(01)RC02_bib5","first-page":"70","article-title":"The Rise and Fall of Insulin Secretion in type 1 diabetes mellitus","volume":"49","author":"Tsai","year":"2006","journal-title":"Diabetologia"},{"issue":"1","key":"10.6061\/clinics\/2013(01)RC02_bib6","first-page":"64","article-title":"C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001","volume":"53","author":"Palmer","year":"2004","journal-title":"Diabetes"},{"issue":"2","key":"10.6061\/clinics\/2013(01)RC02_bib7","first-page":"84","article-title":"Markers of beta cell function in type 1 diabetes mellitus","volume":"95","author":"Vendrame","year":"2004","journal-title":"Minerva Med"},{"issue":"3","key":"10.6061\/clinics\/2013(01)RC02_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2337\/diacare.26.3.832","article-title":"b-cell Function and the development of diabetes-related complications in diabetes control and complication trial","volume":"26","author":"Steffes","year":"2003","journal-title":"Diabetes Care"},{"key":"10.6061\/clinics\/2013(01)RC02_bib9","doi-asserted-by":"crossref","unstructured":"Sherry NA, Tsai EB, Palmer JP, Herold KC. Natural history of beta cell function in type 1 diabetes. Diabetes 54 Suppl 2:S32-9.","DOI":"10.2337\/diabetes.54.suppl_2.S32"},{"issue":"7","key":"10.6061\/clinics\/2013(01)RC02_bib10","first-page":"53","article-title":"A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group","volume":"128","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.6061\/clinics\/2013(01)RC02_bib11","first-page":"71","article-title":"Diagnosis and classification of diabetes mellitus (position statements)","volume":"35 Suppl1","year":"2012","journal-title":"Diabetes Care"},{"issue":"6","key":"10.6061\/clinics\/2013(01)RC02_bib12","first-page":"446","article-title":"Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications","volume":"22","author":"Scheen","year":"1996","journal-title":"Diabetes Metab"},{"issue":"10","key":"10.6061\/clinics\/2013(01)RC02_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2337\/dc07-2451","article-title":"Mixed-meal tolerance test versus glucagon stimulation test for the assessment of \u03b2-cell function in therapeutic trials in type 1 diabetes","volume":"31","author":"Greenbaum","year":"2008","journal-title":"Diabetes Care"},{"issue":"9","key":"10.6061\/clinics\/2013(01)RC02_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00278749","article-title":"Factors influencing the magnitude, duration, and rate of fall of b-cell function in type 1 (insulin dependent) diabetic children followed for two years from their clinical diagnosis","volume":"31","author":"Wallensten","year":"1988","journal-title":"Diabetologia"},{"issue":"1","key":"10.6061\/clinics\/2013(01)RC02_bib15","first-page":"6","article-title":"The DCCT Research Group","volume":"65","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.6061\/clinics\/2013(01)RC02_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2337\/diabetes.53.2.426","article-title":"Insulin Secretion In Type 1 Diabetes","volume":"53","author":"Steele","year":"2004","journal-title":"Diabetes"},{"issue":"11","key":"10.6061\/clinics\/2013(01)RC02_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2337\/db10-0676","article-title":"Residual insulin production and pancreatic cell turnover after 50 years of diabetes: Joslin Medalist Study","volume":"59","author":"Keenan","year":"2010","journal-title":"Diabetes"},{"issue":"3","key":"10.6061\/clinics\/2013(01)RC02_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2337\/dc11-1236","article-title":"Persistence of Prolonged C-peptide Production in Type 1 Diabetes as Measured With an Ultrasensitive C-peptide Assay","volume":"35","author":"Wang","year":"2012","journal-title":"Diabetes Care"},{"issue":"10","key":"10.6061\/clinics\/2013(01)RC02_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1590\/S0100-879X1999001000003","article-title":"Frequency of islet cell autoantibodies (IA-2 And GAD) in young Brazilian type 1 Diabetes patients","volume":"32","author":"Pardini","year":"1999","journal-title":"Braz J Med Biol Res"},{"issue":"11","key":"10.6061\/clinics\/2013(01)RC02_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1590\/S0100-879X2004001100008","article-title":"Relationship between the prevalence of anti-glutamic acid descarboxilase autoantibodies and duration of type 1 diabetes mellitus in Brazilian patients","volume":"37","author":"Rodacki","year":"2004","journal-title":"Braz J Med Biol Res"},{"issue":"6","key":"10.6061\/clinics\/2013(01)RC02_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/152091502321118838","article-title":"Type 1 diabetes islet autoantibody markers","volume":"4","author":"Winter","year":"2002","journal-title":"Diabetes Technol Ther"},{"issue":"9","key":"10.6061\/clinics\/2013(01)RC02_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/diacare.28.9.2170","article-title":"The role of autoimmunity at diagnosis of type 1 diabetes in the development of thyroid and celiac disease and microvascular complications","volume":"28","author":"Glastras","year":"2005","journal-title":"Diabetes Care"},{"issue":"3","key":"10.6061\/clinics\/2013(01)RC02_bib23","first-page":"72","article-title":"[Diabetes mellitus in adult patients with type I diabetes shows immunological, functional and clinical differences depending on the presence of autoimmune thyroiditis]","volume":"146","author":"Vondra","year":"2007","journal-title":"Cas Lek Cesk"},{"issue":"5","key":"10.6061\/clinics\/2013(01)RC02_bib24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/BF00252760","article-title":"Effect of strict blood glucose control on residual b-cell function in insulin-dependent diabetics","volume":"20","author":"Madsbad","year":"1981","journal-title":"Diabetologia"},{"issue":"1","key":"10.6061\/clinics\/2013(01)RC02_bib25","first-page":"22","article-title":"Residual C-peptide excretion is associated with better long-term glycemic control and slower progress of retinopathy in type 1 (insulin-dependent) diabetes mellitus","volume":"5","author":"Sj\u00f6berg","year":"1991","journal-title":"J Diabetes Complications"},{"issue":"12","key":"10.6061\/clinics\/2013(01)RC02_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1464-5491.1999.00181.x","article-title":"Higher post-absortive C-peptide levels in type 1 diabetic patients without renal complications","volume":"16","author":"Zerbini","year":"1999","journal-title":"Diabet Med"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222021378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222021378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/cln-68-01\/cln-68-01-123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:10:21Z","timestamp":1761721821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222021378"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1807-59322013000100023&lng=en&nrm=iso","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3552451\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"alternative-id":["S1807593222021378"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2013(01)rc02","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2013(01)RC02","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}